Guizhou Yibai Pharmaceutical Co Ltd Market Cap ($369.67 Million)

$369.67 Million USD · CN¥2.53 Billion CNY · Rank #13480

Market Cap & Net Worth: Guizhou Yibai Pharmaceutical Co Ltd (600594)

Guizhou Yibai Pharmaceutical Co Ltd market cap. Guizhou Yibai Pharmaceutical Co Ltd (SHG:600594) has a market capitalization of $369.67 Million (CN¥2.53 Billion) as of November 1, 2026. Listed on the SHG stock exchange, this China-based company holds position #13480 globally and #3928 in its home market, demonstrating a -2.15% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Guizhou Yibai Pharmaceutical Co Ltd's stock price CN¥3.19 by its total outstanding shares 791927400 (791.93 Million). Also see cash flow conversion of Guizhou Yibai Pharmaceutical Co Ltd for how efficiently the company converts equity into cash flow.

Guizhou Yibai Pharmaceutical Co Ltd Market Cap History (2015–2026)

Guizhou Yibai Pharmaceutical Co Ltd market cap history from 2015 to 2026. Data shows change from $2.16 Billion to $369.67 Million (-13.76% CAGR). Check current stock price of Guizhou Yibai Pharmaceutical Co Ltd for real-time trading data and today's change.

Guizhou Yibai Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Guizhou Yibai Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Guizhou Yibai Pharmaceutical Co Ltd annual equity growth to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

0.25x

Guizhou Yibai Pharmaceutical Co Ltd's market cap is 0.25 times its annual revenue

Industry average: 0.56x Lower than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$1.70 Billion	$3.69 Billion	$384.86 Million	0.46x	4.42x
2017	$1.05 Billion	$3.81 Billion	$387.53 Million	0.28x	2.70x
2018	$569.08 Million	$3.88 Billion	-$725.50 Million	0.15x	N/A
2019	$513.41 Million	$3.36 Billion	$141.90 Million	0.15x	3.62x
2020	$591.63 Million	$3.41 Billion	$228.76 Million	0.17x	2.59x
2021	$942.14 Million	$3.35 Billion	$243.77 Million	0.28x	3.86x
2022	$640.84 Million	$2.74 Billion	-$426.39 Million	0.23x	N/A
2023	$659.38 Million	$2.82 Billion	$103.40 Million	0.23x	6.38x
2024	$412.55 Million	$2.17 Billion	-$317.22 Million	0.19x	N/A
2025	$461.22 Million	$1.86 Billion	-$329.56 Million	0.25x	N/A

Competitor Companies of 600594 by Market Capitalization

Companies near Guizhou Yibai Pharmaceutical Co Ltd in the global market cap rankings as of November 1, 2026. Also see Guizhou Yibai Pharmaceutical Co Ltd assets under control for a full breakdown of the balance sheet.

Key companies related to Guizhou Yibai Pharmaceutical Co Ltd by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#511	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#535	GALDERMA GROUP AG	NYSE:GALDY	$50.42 Billion	$46.62
#593	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$45.23 Billion	CN¥48.46
#619	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€18.30

Market Capitalization of Guizhou Yibai Pharmaceutical Co Ltd (2015–2026)

Market capitalization of Guizhou Yibai Pharmaceutical Co Ltd from 2015 to today. Between 2015 and today, Guizhou Yibai Pharmaceutical Co Ltd's market cap moved from $2.16 Billion to $ 369.67 Million, with a yearly change of -13.76%.

Year	Market Cap	Change (%)
2026	CN¥369.67 Million	-19.85%
2025	CN¥461.22 Million	+11.80%
2024	CN¥412.55 Million	-37.43%
2023	CN¥659.38 Million	+2.89%
2022	CN¥640.84 Million	-31.98%
2021	CN¥942.14 Million	+59.24%
2020	CN¥591.63 Million	+15.24%
2019	CN¥513.41 Million	-9.78%
2018	CN¥569.08 Million	-45.69%
2017	CN¥1.05 Billion	-38.35%
2016	CN¥1.70 Billion	-21.37%
2015	CN¥2.16 Billion	--

End of Day Market Cap According to Different Sources

On Oct 31st, 2026 the market cap of Guizhou Yibai Pharmaceutical Co Ltd was reported to be:

Source	Market Cap
Yahoo Finance	$369.67 Million USD
MoneyControl	$369.67 Million USD
MarketWatch	$369.67 Million USD
marketcap.company	$369.67 Million USD
Reuters	$369.67 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Guizhou Yibai Pharmaceutical Co Ltd

SHG:600594 China Drug Manufacturers - Specialty & Generic

Market Cap

$369.67 Million

CN¥2.53 Billion CNY

Market Cap Rank

#13480 Global

#3928 in China

Share Price

CN¥3.19

Change (1 day)

+0.00%

52-Week Range

CN¥2.95 - CN¥5.06

All Time High

CN¥19.64